INTEST CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.49 USD | -4.65% |
|
-13.15% | -15.51% |
| Mar. 28 | InTEST Seeks Acquisitions | CI |
| Mar. 28 | Transcript : InTEST Corporation, Q4 2023 Earnings Call, Mar 28, 2024 |
Financials (USD)
| Sales 2024 * | 150M | Sales 2025 * | 169M | Capitalization | 144M |
|---|---|---|---|---|---|
| Net income 2024 * | 9M | Net income 2025 * | 11M | EV / Sales 2024 * | 0.96 x |
| Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.86 x |
| P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
13
x | Employees | 329 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on inTEST Corporation
More recommendations
More press releases
| 1 day | -0.58% | ||
| 1 week | -9.06% | ||
| Current month | -9.06% | ||
| 1 month | +7.49% | ||
| 3 months | +0.42% | ||
| 6 months | -13.99% | ||
| Current year | -11.40% |
1 week
11.82
13.25
1 month
10.8114.35
Current year
10.8114.35
1 year
10.6627.17
3 years
6.0727.17
5 years
2.0827.17
10 years
2.0827.17
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Grant
CEO | Chief Executive Officer | 54 | 20-08-23 |
Duncan Gilmour
DFI | Director of Finance/CFO | 52 | 21-06-13 |
Meghan Blount
HRO | Human Resources Officer | - | 22-02-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Gerald Maginnis
BRD | Director/Board Member | 68 | 20-06-23 |
Jeffrey Beck
BRD | Director/Board Member | 61 | 18-12-31 |
Steven Abrams
BRD | Director/Board Member | 56 | 13-01-07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.97% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-15 | 11.49 | -4.65% | 103,756 |
| 24-04-12 | 12.05 | -0.58% | 122,252 |
| 24-04-11 | 12.12 | +1.51% | 142,486 |
| 24-04-10 | 11.94 | -5.54% | 136,817 |
| 24-04-09 | 12.64 | -4.46% | 120,438 |
Delayed Quote Nyse, April 12, 2024 at 04:00 pm EDT
More quotes
inTEST Corporation is a supplier of test and process technology solutions for use in manufacturing and testing. The Companyâs segments include Electronic Test, Environmental Technologies and Process Technologies. Electronic Test consists of inTEST EMS, which has operations in New Jersey and California, and Acculogic, which has operations in Canada, California and Germany. Environmental Technologies consists of inTEST Thermal Solutions (iTS), which manufactures and sells products under the Temptronic, Sigma, Thermonics and North Sciences brand names and has operations in Massachusetts, Germany and Singapore. Process Technologies consists of Ambrell, which has operations in New York, the Netherlands and the United Kingdom, and Videology, which has operations in Massachusetts and the Netherlands. Its key markets include automotive, defense/aerospace, industrial, life sciences, and security, as well as both the front-end and back-end of the semiconductor manufacturing industry.
Calendar
2024-05-02
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
12.05
USD
Average target price
18
USD
Spread / Average Target
+49.38%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -11.40% | 144M | |
| +58.54% | 6.34B | |
| +21.83% | 3.4B | |
| -7.84% | 3.26B | |
| -7.48% | 2.21B | |
| -24.43% | 1.97B | |
| -2.03% | 1.77B | |
| -23.03% | 1.08B | |
| +6.81% | 1.03B | |
| -19.70% | 896M |
- Stock Market
- Equities
- INTT Stock
